Rapid Micro Biosystems RPID
NASDAQ RPID
$1.67 -0.03 (-1.47%)
At close: Aug 20, 2026 · 2:35 PM UTC

Rapid Micro Biosystems (RPID) Net Income Growth (3y) (2023 - 2026)

Rapid Micro Biosystems (RPID) Net Income Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn -12.28%
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 20.02%
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 1.93%
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 49.66%
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn -7.83%
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 29.05%
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 9.85%
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 43.60%
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 17.54%
10 Rapid Micro Biosystems 81.22 Mn 61.46 Mn 1.21 Mn 2.67%

Historic Data

Download Data
DateValue
Jun 30, 2026 2.67%
Mar 31, 2026 -0.92%
Dec 31, 2025 8.78%
Sep 30, 2025 11.03%
Jun 30, 2025 3.27%
Mar 31, 2025 8.97%
Dec 31, 2024 12.85%
Sep 30, 2024 23.19%
Jun 30, 2024 -2.06%
Mar 31, 2024 15.53%
Dec 31, 2023 0.49%
Sep 30, 2023 -16.52%
Jun 30, 2023 -14.79%